Iron induces Bcl-2 expression in human dermal microvascular endothelial cells

References

• Sussman H.H. Iron in cancer. Pathobiology 1992; 60: 2–9
   PubMedGoogle Scholar
• Weinberg E.D. The role of iron in cancer. European Journal of Cancer Prevention 1996; 5: 19–36
   PubMed Web of Science ®Google Scholar
• Ludin P.M. The carcinogenic action of complex iron preparations. British Journal of Cancer 1961; 15: 838–847
   PubMedGoogle Scholar
• Robertson A.G., Dick W.C. Intramuscular iron and local oncogenesis. British Medical Journal 1977; 1: 947–949
   Google Scholar
• Stevens R.G., Graubard B.I., Micozzi M.S., Neriishi K., Blumberg B.S. Moderate elevation of body iron level and increased risk of cancer occurrence and death. International Journal of Cancer 1994; 56: 364–369
   PubMed Web of Science ®Google Scholar
• Bradbear R.A., Bain C., Siskind V. Cohort study of internal malignancy in genetic hemochromatosis and other chronic nonalcoholic liver disease. Journal of the National Cancer Institute 1985; 75: 81–84
   PubMed Web of Science ®Google Scholar
• De Souza M., Potaznik D. Proteins of the metabolism of iron. Cells of the immune system and malignancy. Vitamin nutrition and cancer, J.S. Prasad. Karger, Basel 1984; 231–239, In
   Google Scholar
• Boelaert J.R., Weinberg G.A., Weinberg E.D. Altered iron metabolism in HIV infection: mechanisms, possible consequences, and proposals for management. Infectious Agents and Disease 1996; 5: 36–46
   PubMedGoogle Scholar
• Simonart T., Noel J.C., Andrei G., Parent D., Van Vooren J.P., Hermans P., Lunardi-Yskandar Y., Lambert C., Dieye T., Farber C.M., Liesnard C., Snoeck R., Heenen M., Boelaert J.R. Iron as a potential cofactor in the pathogenesis of Kaposi's sarcoma. International Journal of Cancer 1998a; 78: 720–726
   PubMed Web of Science ®Google Scholar
• Cazzola M., Bergamaschi G., Dezza L., Arosio P. Manipulations of cellular iron metabolism for modulating normal and malignant cell proliferation. Blood 1990; 75: 1903–1919
   PubMed Web of Science ®Google Scholar
• Folkman J. Clinical applications of research on angiogenesis. New England Journal of Medicine 1995; 333: 1757–1763
   PubMed Web of Science ®Google Scholar
• Oltvai Z., Milliman C.L., Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609–619
   PubMed Web of Science ®Google Scholar
• Hase M., Araki S., Kaji K., Hayashi H. Classification of signals for blocking apoptosis in vascular endothelial cells. Journal of Biochemistry 1994; 116: 905–909
   PubMed Web of Science ®Google Scholar
• Kondo S., Yin D., Aoki T., Takahashi J.A., Morimura T., Takeuchi J. Bcl-2 gene prevents apoptosis of basic fibroblast growth-factor-deprived murine aortic endothelial cells. Experimental Cell Research 1994; 213: 428–432
   PubMedGoogle Scholar
• Karsan A., Kaushansky K., Harlan J.M., Yee E. Cloning of a human Bcl-2 homologue: inflammatory cytokines induce human A1 in cultured endothelial cells. Blood 1996; 87: 3089–3096
   PubMed Web of Science ®Google Scholar
• Strasser A., Harris A.W., Cory S. Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 1991; 67: 889–989
   PubMed Web of Science ®Google Scholar
• Bohan Morris C., Gendelman R., Marrogi A.J., Lu M., Lockyer J.M., Alperin-Lea W., Ensoli B. Immunohistochemical detection of Bcl-2 in AIDS-associated and classical Kaposi's sarcoma. American Journal of Pathology 1996; 148: 1055–1063
   PubMedGoogle Scholar
• Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Medicine 1997; 3: 614–620
   PubMed Web of Science ®Google Scholar
• Kluger M.S., Johnson D.R., Pober J.S. Mechanism of sustained E-selectin expression in human dermal microvascular endothelial cells. Journal of Immunology 1997; 158: 887–896
   PubMed Web of Science ®Google Scholar
• Saalbash A., Anderegg U., Bruns M., Schnabel E., Herrmann K., Haustein U.F. Novel fibroblast-specific monoclonal antibodies: properties and specificities. Journal of Investigative Dermatology 1996; 106: 1314–1319
   PubMedGoogle Scholar
• Hébert L., Pandey S., Wang E. Commitment to cell death is signaled by the appearance of a terminin protein of 30k. Experimental Cell Research 1994; 210: 10–18
   PubMedGoogle Scholar
• Lillie R.D. Histopathologic technic and practical histochemistry3rd Edition. McGraw-Hill Book Co, New York 1965; 407–407
   Google Scholar
• Galand P., Del Bino G., Morret M., Capel P., Degraef C., Fokan D., Feremans W. PCNA immunopositivity index as a substitute to 3H-thymidine pulse-labeling index (TLI) in methanol-fixed human lymphocytes. Leukemia 1995; 9: 1075–1084
   PubMed Web of Science ®Google Scholar
• Heenen M., Laporte M., Noel J.C., Degraef C. Methotrexate induces apoptotic cell death in human keratinocytes. Archives of Dermatological Research 1998; 290: 240–245
   PubMedGoogle Scholar
• Simonart T., Degraef C., Noel J.C., Fokan D., Zhou L., Pradier O., Ducarme M., Schandene L., Van Vooren J.P., Parent D., Heenen M. Overexpression of Bcl-2 in Kaposi's sarcoma-derived cells. Journal of Investigative Dermatology 1998b; 111: 349–353
   PubMedGoogle Scholar
• Miyashita T., Kitada S., Krajeweski S., Horne W.A., Delia D., Reed J.C. Overexpression of the Bcl-2 protein increases the half-life of p21Bax. Journal of Biological Chemistry 1995; 270: 26049–26052
   PubMed Web of Science ®Google Scholar
• Zoellner H., Höfler M., Beckmann R., Hufnag P., Vanyek E., Bielek E., Wojta J., Fabry A., Lockie S., Bindeer B.R. Serum albumin is a specific inhibitor of apoptosis in human endothelial cells. Journal of Cell Science 1996; 109: 2571–2580
   PubMed Web of Science ®Google Scholar
• Kurky P., Ogata K., Tan E.M. Monoclonal antibodies to proliferating cell nuclear antigen (PCNA)/cyclin as probes for proliferating cells by immunofluorescence microscopy and flow cytometry. Journal of Immunological Methods 1988; 109: 49–59
   PubMedGoogle Scholar
• Garland J.M., Halestrap A. Energy metabolism during apoptosis. Journal of Biological Chemistry 1997; 8: 4680–4688
   Google Scholar
• Regezi J.A., Macphail L.A., Daniels T.E., Desouza Y.G., Greenspan J.S., Greenspan D. Human immunodeficiency virus-associated oral Kaposi's sarcoma. A heterogeneous cell population dominated by spindle-shaped endothelial cells. American Journal of Pathology 1993; 143: 240–249
   PubMed Web of Science ®Google Scholar
• Fiorelli V., Gendelman R., Samaniego F., Markham P.D., Ensoli B. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells. Journal of Clinical Investigation 1995; 95: 1723–1734
   PubMed Web of Science ®Google Scholar
• Blankaert D., Simonart T., Van Vooren J.P., Parent D., Liesnard C., Farber C.M., Marique T., Werenne J. Constitutive release of metalloproteinase-9 (92-kDa type IV collagenase) by Kaposi's sarcoma cells. Journal of Acquired Immune Deficiency Syndromes 1998; 18: 203–209
   Google Scholar
• Sutherland R., Delia D., Schneider C., Newman R., Kemshead J., Greaves M. Ubiquitous cell surface glycoprotein on tumor cells is proliferation associated receptor for transferrin. Proceedings of the National Academy of Sciences of the United States of America 1981; 78: 4515–4519
   PubMed Web of Science ®Google Scholar
• Sironi M., Breviaro F., Proserpio P., Biondi A., Vechi A., Van Damme J., Dejana E., Mantovani A. IL-1 stimulates IL-6 production in endothelial cells. Journal of Immunology 1989; 142: 549–553
   PubMed Web of Science ®Google Scholar
• Reichard P., Ehrenberg A. Ribonucleotide reductase: A radical enzyme. Science 1983; 221: 514–519
   PubMed Web of Science ®Google Scholar
• Sakakura C., Sweeney E.A., Shirahama T., Hakomori S., Igarashi Y. Suppression of Bcl-2 gene expression by sphingosine in the apoptosis of human leukemic HL-60 cells during phorbol ester-induced terminal differentiation. FEBS Letters 1996; 379: 177–180
   PubMedGoogle Scholar
• Saegusa M., Okayasu I. Down-regulation of bcl-2 expression is closely related to squamous differentiation and progesterone therapy in endometrial carcinomas. Journal of Pathology 1997; 182: 429–436
   PubMedGoogle Scholar
• Dawson C.W., Eliopoulos A.G., Dawson J., Young L.S. BHRF1, a viral homologue of the Bcl-2 oncogene, disturbs epithelial cell differentiation. Oncogene 1995; 9: 69–77
   Google Scholar
• Gerber H.P., Dixit V., Ferrara N. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. Journal of Biological Chemistry 1998; 273: 13313–13316
   PubMed Web of Science ®Google Scholar
• Hockenbery D.M., Oltvai Z.N., Yin X.M., Milliman C.L., Korsmeyer S.J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993; 75: 241–251
   PubMed Web of Science ®Google Scholar
• Borner C. Diminished cell proliferation associated with the death-protective activity of Bcl-2. Journal of Biological Chemistry 1996; 271: 12695–12698
   PubMed Web of Science ®Google Scholar